Details for Patent: 12,161,656

Which drugs does patent 12,161,656 protect, and when does it expire?

Patent 12,161,656 protects MINOCIN and is included in one NDA.

This patent has thirty patent family members in twenty-two countries.

Summary for Patent: 12,161,656

Title:	Tetracycline compositions
Abstract:	Compositions, pharmaceutical compositions, and methods for preparing the same, comprising a tetracycline with improved stability and solubility, are disclosed. Some embodiments include a tetracycline with an excess of a divalent or trivalent cation.
Inventor(s):	David C. Griffith, Serge Henri Boyer, Scott J. Hecker, Michael N. Dudley
Assignee:	Melinta Subsidiary Corp
Application Number:	US18/583,643
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 12,161,656
Patent Claim Types: see list of patent claims	Formulation; Compound;

Drugs Protected by US Patent 12,161,656

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Rempex	MINOCIN	minocycline hydrochloride	INJECTABLE;INJECTION	050444-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes	12,161,656		Y

International Family Members for US Patent 12,161,656

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2011252919
Brazil	112012028524
Canada	2799079
Chile	2012003168
China	102970992
Colombia	6650346
Denmark	2568987